Comparison of insulin lispro protamine suspension versus insulin glargine once daily added to oral antihyperglycaemic medications and exenatide in type 2 diabetes: a prospective randomized open‐label trial

ConclusionsILPS was non‐inferior to glargine for HbA1c change over 24 weeks, but was associated with less HbA1c reduction and more nocturnal hypoglycaemia. Treat‐to‐target basal insulin therapy improves glycaemic control and is associated with minimal weight gain when added to OAMs and exenatide BID for suboptimally controlled T2D.

Source: Diabetes, Obesity and Metabolism - December 29, 2013 Category: Endocrinology Authors: R. F. Arakaki, T. C. Blevins, J. K. Wise, D. R. Liljenquist, H. H. Jiang, J. G. Jacobson, S. A. Martin, J. A. Jackson Tags: ORIGINAL ARTICLE Source Type: research